No Data
No Data
No Data
No Data
No Data
We're Interested To See How Arcturus Therapeutics Holdings (NASDAQ:ARCT) Uses Its Cash Hoard To Grow
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring
Simply Wall StApr 17 06:25 ET
As More Rare Disease Therapies Launch, Their Prices Are Rising
Seeking AlphaApr 16 12:22 ET
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Yahoo FinanceMar 28 01:34 ET
Arcturus Therapeutics(ARCT.US) Officer Sells US$610.57K in Common Stock
$Arcturus Therapeutics(ARCT.US)$ Officer Chivukula Pad sold 17,435 shares of Common Stock on Mar 25, 2024 at an average price of $35.02 for a total value of $610.57K.Source: Announcement What is state
moomoo NewsMar 27 16:58 ET
Arcturus Therapeutics Holdings Insider Sold Shares Worth $610,574, According to a Recent SEC Filing
Pad Chivukula, Chief Scientific Officer & COO, on March 25, 2024, sold 17,435 shares in Arcturus Therapeutics Holdings (ARCT) for $610,574. Following the Form 4 filing with the SEC, Chivukula has cont
MT NewswiresMar 27 16:22 ET
Optimistic Buy Rating for Arcturus Therapeutics Amid Strong Kostaive Vaccine Market Prospects in Japan
TipRanksMar 26 07:15 ET
No Data
No Data